Rising Costs Will Restrict Returns Amid Modest Margin Relief
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 14 Analysts
Published
13 May 25
Updated
16 Aug 25
AnalystLowTarget's Fair Value
US$5.16
22.0% overvalued intrinsic discount16 Aug
US$6.29
1Y
4.8%7D
-0.5%